O'Shaughnessy Asset Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $607K | Buy |
|
|||||
|
2025
Q1 | $357K | Sell |
|
|||||
|
2024
Q4 | $515K | Sell |
|
|||||
|
2024
Q3 | $444K | Sell |
|
|||||
|
2024
Q2 | $588K | Buy |
|
|||||
|
2024
Q1 | $510K | Buy |
|
|||||
|
2023
Q4 | $417K | Buy |
|
|||||
|
2023
Q3 | $344K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $239K | Sell |
|
|||||
|
2022
Q4 | $347K | Buy |
|
|||||
|
2022
Q3 | $270K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $118K | Sell |
|
|||||
|
2021
Q2 | $224K | Buy |
|
|||||
|
2021
Q1 | $220K | Sell |
|
|||||
|
2020
Q4 | $242K | Buy |
|
|||||
|
2020
Q3 | $172K | Buy |
|
|||||
|
2020
Q2 | $148K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $2K | Buy |
|